Abstract CT316: A phase I trial of oral TRC102 (methoxyamine HCl) in combination with temozolomide (TMZ) in patients with relapsed solid tumorsWoondong Jeong, Shivaani Kummar, Alice P. Chen et al.|Cancer Research|2015Cited by 1